Skip to main content

Advertisement

Fig. 1 | BMC Medicine

Fig. 1

From: The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance

Fig. 1

Participating WANETAM sites. Coordinated by the Medical Research. Council Unit (MRC), The Gambia, the following partner sites were part of the capacity building activities and drug resistance surveys: (1) Senegal, Laboratoire Bactériologie Virologie, Le Dantec, Dakar; (2) The Gambia, National Public Health Laboratory Services, Banjul; (3) Guinea-Bissau, National Institute of Public Health (INASA), Bissau; (4) Mali, SEREFO (HIV/TB Research and Training Center) FMOS, University of STT, Bamako; (5) Burkina Faso, Centre Muraz and the National TB Program (NTP), Ouagadougou; (6) Ghana, Korle Bu Teaching Hospital, Accra; (7) Togo, Laboratoire National de Référence (LNR) des Mycobactéries, Lome; (8) Nigeria, Nigerian Institute of Medical Research (NIMR), Lagos; (9) Nigeria, College of Medicine, University of Ibadan

Back to article page